Study of Efficacy and Safety of LCZ696 in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction
Clinical trial NCT02468232 · COMPLETED
Trial details
- NCT number
- NCT02468232
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-15
- Primary completion
- 2019-02-08
- Enrollment
- 225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.